Outcome of Board Meeting dated May 29, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aimco Pesticides' Board approved audited standalone and consolidated financial results for Q4 and full year ended March 31, 2025. Full-year standalone revenue from operations fell to ₹19,730.70 lakhs from ₹20,723.38 lakhs in FY24 (down about 5%), while consolidated revenue was ₹19,765.89 lakhs versus ₹20,721.65 lakhs. The company reported a net loss of ₹738.57 lakhs standalone and ₹724.34 lakhs consolidated for FY25, though narrower than FY24 losses of ₹979.44 lakhs and ₹1,004.60 lakhs respectively. Loss per share stood at ₹7.70 (standalone) and ₹7.55 (consolidated). Statutory auditors CNK & Associates LLP issued an unmodified opinion on the results. The Board also re-appointed M/s. V.J. Talati & Co. as Cost Auditor for FY26 and appointed M/s. S.V. Kulkarni and Associates as Secretarial Auditor for five years (FY26–FY30).
The company remains in the red with a second consecutive year of losses, but the loss narrowed and operating cash flow stayed positive, suggesting some operational improvement despite a revenue dip. Investors should note the going concern context: business continues to incur losses, though auditor gave a clean, unmodified opinion, which is a positive signal. Shareholders should watch for signs of a return to profitability in upcoming quarters.